Characteristic | Number of cases | Percentage |
---|---|---|
Menopausal status | ||
Premenopause | 668 | 71.4 |
Postmenopause | 268 | 28.6 |
Histotype | ||
Tubular carcinoma | 14 | 1.5 |
Invasive ductal carcinoma | 825 | 88.2 |
Invasive lobular carcinoma | 91 | 9.7 |
Other | 6 | 0.6 |
Histologic grade | ||
Grade 1 | 151 | 16.0 |
Grade 2 | 493 | 53.0 |
Grade 3 | 292 | 31.0 |
Lymph node status | ||
Negative | 539 | 58.0 |
Positive | 397 | 42.0 |
Tumor size | ||
T1 | 579 | 62.0 |
T2 | 290 | 31.0 |
T3,4 | 67 | 7.0 |
Estrogen receptor-beta | ||
Negative | 416 | 44.0 |
Positive | 520 | 56.0 |
Estrogen receptor-alpha | ||
Negative | 278 | 30.0 |
Positive | 658 | 70.0 |
Progesterone receptor | ||
Negative | 368 | 39.0 |
Positive | 568 | 61.0 |
HER2 | ||
Negative (0/1+) | 635 | 68.0 |
Positive (2+/3+) | 183 | 32.0 |
Ki67 expression | ||
Low | 529 | 56.0 |
High | 407 | 44.0 |
p53 | ||
Negative | 714 | 76.0 |
Positive | 222 | 23.0 |
Bcl2 | ||
Negative | 297 | 32.0 |
Positive | 639 | 68.0 |